VORICONAZOLE FOR INJECTION
Google image searchProduct monograph
Active ingredient
voriconazole, 200 MG/VIAL
DIN: 02493829
Dosage form(s): POWDER FOR SOLUTION
Route(s) of administration: INTRAVENOUS
Schedule: Prescription
Company: FRESENIUS KABI CANADA LTD
Date: 01-SEP-2021
ATC:
- J02 — ANTIMYCOTICS FOR SYSTEMIC USE (ATC, ATC/DDD, )
- J02A — ANTIMYCOTICS FOR SYSTEMIC USE (ATC, ATC/DDD)
- J02AC — Triazole derivatives (ATC, ATC/DDD)
- J02AC03 — VORICONAZOLE (ATC/DDD)
Reference brand drug: Vfend
Pharmaceutical standard: MFR
